References
Key articles
Dason ES, Maxim M, Sanders A, et al; Society of Obstetricians and Gynaecologists of Canada (SOGC). Guideline no. 437: diagnosis and management of adenomyosis. J Obstet Gynaecol Can. 2023 Jun;45(6):417-29.e1.Full text Abstract
National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. Mar 2018; updated May 2021 [internet publication].Full text
Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec;143(3):393-408. Abstract
American College of Obstetricians and Gynecologists; Committee on Practice Bulletins - Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul;120(1):197-206.Full text Abstract
Reference articles
1. Van den Bosch T, de Bruijn AM, de Leeuw RA, et al. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019 May;53(5):576-82.Full text Abstract
2. Dason ES, Maxim M, Sanders A, et al; Society of Obstetricians and Gynaecologists of Canada (SOGC). Guideline no. 437: diagnosis and management of adenomyosis. J Obstet Gynaecol Can. 2023 Jun;45(6):417-29.e1.Full text Abstract
3. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. Mar 2018; updated May 2021 [internet publication].Full text
4. Bergholt T, Eriksen L, Berendt N, et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001 Nov;16(11):2418-21. Abstract
5. Curtis KM, Hillis SD, Marchbanks PA, et al. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol. 2002 Sep;187(3):543-4. Abstract
6. Naftalin J, Hoo W, Pateman K, et al. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012 Dec;27(12):3432-9. Abstract
7. Pinzauti S, Lazzeri L, Tosti C, et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015 Dec;46(6):730-6.Full text Abstract
8. Bourdon M, Santulli P, Marcellin L, et al. Adenomyosis: an update regarding its diagnosis and clinical features. J Gynecol Obstet Hum Reprod. 2021 Dec;50(10):102228. Abstract
9. Taran FA, Stewart EA, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013 Sep;73(9):924-31.Full text Abstract
10. Parker JD, Leondires M, Sinaii N, et al. Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril. 2006 Sep;86(3):711-5.Full text Abstract
11. Royal College of Obstetricians and Gynaecologists. The initial management of chronic pelvic pain (Green-top Guideline no. 41). May 2012 [internet publication].Full text
12. Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril. 2008 Aug;90(2):415-24.Full text Abstract
13. García-Solares J, Donnez J, Donnez O, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018 Mar;109(3):371-9.Full text Abstract
14. Gargett CE, Schwab KE, Zillwood RM, et al. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod. 2009 Jun;80(6):1136-45.Full text Abstract
15. Zhai J, Vannuccini S, Petraglia F, et al. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med. 2020 May;38(2-03):129-43.Full text Abstract
16. Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A) - pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017 Apr;40:68-81. Abstract
17. Isaacson K, Loring M. Symptoms of adenomyosis and overlapping diseases. Semin Reprod Med. 2020 May;38(2-03):144-50. Abstract
18. Cohen I, Beyth Y, Tepper R, et al. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity? Gynecol Oncol. 1995 Jul;58(1):86-91. Abstract
19. Cohen I, Beyth Y, Shapira J, et al. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest. 1997;44(3):200-5. Abstract
20. Kitawaki J, Noguchi T, Amatsu T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 1997 Sep;57(3):514-9. Abstract
21. Kitawaki J, Koshiba H, Ishihara H, et al. Progesterone induction of 17beta-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogen-dependent benign diseases but not in normal endometrium. J Clin Endocrinol Metab. 2000 Sep;85(9):3292-6. Abstract
22. Nie J, Liu X, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 2010 Nov;17(11):995-1005. Abstract
23. Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Investig. 2011 Mar 1;5(2):125-42. Abstract
24. Shaked S, Jaffa AJ, Grisaru D, et al. Uterine peristalsis-induced stresses within the uterine wall may sprout adenomyosis. Biomech Model Mechanobiol. 2015 Jun;14(3):437-44. Abstract
25. Guo SW. The pathogenesis of adenomyosis vis-à-vis endometriosis. J Clin Med. 2020 Feb 10;9(2):485.Full text Abstract
26. Li T, Li YG, Pu DM. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest. 2006;62(4):229-35. Abstract
27. Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017 Nov;35(5):592-601.Full text Abstract
28. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998 Jul-Aug;4(4):312-22. Abstract
29. Spencer TE, Hayashi K, Hu J, et al. Comparative developmental biology of the mammalian uterus. Curr Top Dev Biol. 2005;68:85-122. Abstract
30. Enatsu A, Harada T, Yoshida S, et al. Adenomyosis in a patient with the Rokitansky-Kuster-Hauser syndrome. Fertil Steril. 2000 Apr;73(4):862-3.Full text Abstract
31. Hoo PS, Norhaslinda AR, Reza JN. Rare case of leiomyoma and adenomyosis in Mayer-Rokitansky-Kuster-Hauser syndrome. Case Rep Obstet Gynecol. 2016;2016:3725043.Full text Abstract
32. Hufnagel D, Li F, Cosar E, et al. The role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med. 2015 Sep;33(5):333-40.Full text Abstract
33. Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update. 2007 Jan-Feb;13(1):87-101.Full text Abstract
34. Ibrahim MG, Chiantera V, Frangini S, et al. Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis. Fertil Steril. 2015 Dec;104(6):1475-83.e1-3.Full text Abstract
35. Martire FG, Lazzeri L, Conway F, et al. Adolescence and endometriosis: symptoms, ultrasound signs and early diagnosis. Fertil Steril. 2020 Nov;114(5):1049-57.Full text Abstract
36. Uduwela AS, Perera MA, Aiqing L, et al. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet Gynecol Surv. 2000 Jun;55(6):390-400. Abstract
37. Upson K, Missmer SA. Epidemiology of adenomyosis. Semin Reprod Med. 2020 May;38(2-03):89-107.Full text Abstract
38. Bulun SE, Yildiz S, Adli M, et al. Endometriosis and adenomyosis: shared pathophysiology. Fertil Steril. 2023 May;119(5):746-50.Full text Abstract
39. Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis. Hum Reprod. 1997 Jun;12(6):1275-9. Abstract
40. Vercellini P, Parazzini F, Oldani S, et al. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod. 1995 May;10(5):1160-2. Abstract
41. Taran FA, Weaver AL, Coddington CC, et al. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010 May;25(5):1177-82.Full text Abstract
42. Jean-Baptiste H, Tetrokalashvili M, Williams T, et al. Characteristics associated with postoperative diagnosis of adenomyosis or combined adenomyosis with fibroids. Int J Gynaecol Obstet. 2013 Aug;122(2):112-4. Abstract
43. Parazzini F, Mais V, Cipriani S, et al. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):103-6. Abstract
44. Panganamamula UR, Harmanli OH, Isik-Akbay EF, et al. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol. 2004 Nov;104(5 pt 1):1034-8. Abstract
45. Trabert B, Weiss NS, Rudra CB, et al. A case-control investigation of adenomyosis: impact of control group selection on risk factor strength. Womens Health Issues. 2011 Mar-Apr;21(2):160-4.Full text Abstract
46. Nasu K, Takai N, Nishida M, et al. Tumorigenic effects of tamoxifen on the female genital tract. Clin Med Pathol. 2008;1:17-34.Full text Abstract
47. Ascher SM, Johnson JC, Barnes WA, et al. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology. 1996 Jul;200(1):105-10. Abstract
48. Taran FA, Wallwiener M, Kabashi D, et al. Clinical characteristics indicating adenomyosis at the time of hysterectomy: a retrospective study in 291 patients. Arch Gynecol Obstet. 2012 Jun;285(6):1571-6. Abstract
49. Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec;143(3):393-408. Abstract
50. American College of Obstetricians and Gynecologists; Committee on Practice Bulletins - Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul;120(1):197-206.Full text Abstract
51. American College of Radiology. ACR appropriateness criteria: abnormal uterine bleeding. 2020 [internet publication].Full text
52. American College of Obstetricians and Gynecologists. ACOG practice bulletin, no. 218: chronic pelvic pain. Obstet Gynecol. 2020 Mar;135(3):e98-109.Full text Abstract
53. Nelsen LM, Lenderking WR, Pokrzywinski R, et al. Experience of symptoms and disease impact in patients with adenomyosis. Patient. 2018 Jun;11(3):319-28.Full text Abstract
54. Puente JM, Fabris A, Patel J, et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016 Sep 20;14(1):60.Full text Abstract
55. Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2021 Jan;42(1):185-206.Full text Abstract
56. Vercellini P, Consonni D, Dridi D, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014 May;29(5):964-77. Abstract
57. Jain V, Munro MG, Critchley HOD. Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2. Int J Gynaecol Obstet. 2023 Aug;162 Suppl 2(suppl 2):29-42.Full text Abstract
58. O'Shea A, Figueiredo G, Lee SI. Imaging diagnosis of adenomyosis. Semin Reprod Med. 2020 May;38(2-03):119-28. Abstract
59. Andres MP, Borrelli GM, Ribeiro J, et al. Transvaginal ultrasound for the diagnosis of adenomyosis: systematic review and meta-analysis. J Minim Invasive Gynecol. 2018 Feb;25(2):257-64. Abstract
60. Moorthy RS. Transvaginal sonography. Med J Armed Forces India. 2000 Jul;56(3):181-3.Full text Abstract
61. Van den Bosch T, Dueholm M, Leone FP, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015 Sep;46(3):284-98.Full text Abstract
62. Harmsen MJ, Van den Bosch T, de Leeuw RA, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022 Jul;60(1):118-31.Full text Abstract
63. Bazot M, Cortez A, Darai E, et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod. 2001 Nov;16(11):2427-33. Abstract
64. Cunningham RK, Horrow MM, Smith RJ, et al. Adenomyosis: a sonographic diagnosis. Radiographics. 2018 Sep-Oct;38(5):1576-89. Abstract
65. Chin LHQ, Li YL, Lee KH. Venetian blind shadowing on ultrasound. Abdom Radiol (NY). 2019 Feb;44(2):796-7. Abstract
66. Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta-analysis of diagnostic accuracy in imaging. J Minim Invasive Gynecol. 2020 Feb;27(2):408-18.e3. Abstract
67. Liu L, Li W, Leonardi M, et al. Diagnostic accuracy of transvaginal ultrasound and magnetic resonance imaging for adenomyosis: systematic review and meta-analysis and review of sonographic diagnostic criteria. J Ultrasound Med. 2021 Nov;40(11):2289-306. Abstract
68. Champaneria R, Abedin P, Daniels J, et al. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010 Nov;89(11):1374-84.Full text Abstract
69. Novellas S, Chassang M, Delotte J, et al. MRI characteristics of the uterine junctional zone: from normal to the diagnosis of adenomyosis. AJR Am J Roentgenol. 2011 May;196(5):1206-13.Full text Abstract
70. Tamai K, Togashi K, Ito T, et al. MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls. Radiographics. 2005 Jan-Feb;25(1):21-40. Abstract
71. Agostinho L, Cruz R, Osório F, et al. MRI for adenomyosis: a pictorial review. Insights Imaging. 2017 Dec;8(6):549-56.Full text Abstract
72. Takeuchi M, Matsuzaki K. Adenomyosis: usual and unusual imaging manifestations, pitfalls, and problem-solving MR imaging techniques. Radiographics. 2011 Jan-Feb;31(1):99-115. Abstract
73. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018 Mar;109(3):389-97.Full text Abstract
74. Davarpanah AH, Kambadakone A, Holalkere NS, et al. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions. Abdom Radiol (NY). 2016 Dec;41(12):2466-75. Abstract
75. McDermott S, Oei TN, Iyer VR, et al. MR imaging of malignancies arising in endometriomas and extraovarian endometriosis. Radiographics. 2012 May-Jun;32(3):845-63. Abstract
76. Jha RC, Zanello PA, Ascher SM, et al. Diffusion-weighted imaging (DWI) of adenomyosis and fibroids of the uterus. Abdom Imaging. 2014 Jun;39(3):562-9. Abstract
77. Rees CO, Nederend J, Mischi M, et al. Objective measures of adenomyosis on MRI and their diagnostic accuracy - a systematic review & meta-analysis. Acta Obstet Gynecol Scand. 2021 Aug;100(8):1377-91.Full text Abstract
78. Gunther R, Walker C. Adenomyosis. In: National Library of Medicine: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.Full text Abstract
79. Munro MG. Classification and reporting systems for adenomyosis. J Minim Invasive Gynecol. 2020 Feb;27(2):296-308. Abstract
80. Simpson WL Jr, Beitia LG, Mester J. Hysterosalpingography: a reemerging study. Radiographics. 2006 Mar-Apr;26(2):419-31. Abstract
81. Movilla P, Morris S, Isaacson K. A systematic review of tissue sampling techniques for the diagnosis of adenomyosis. J Minim Invasive Gynecol. 2020 Feb;27(2):344-51. Abstract
82. Jeng CJ, Huang SH, Shen J, et al. Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis. Hum Reprod. 2007 Jul;22(7):2016-9. Abstract
83. Marques ALS, Andres MP, Mattos LA, et al. Association of 2D and 3D transvaginal ultrasound findings with adenomyosis in symptomatic women of reproductive age: a prospective study. Clinics (Sao Paulo). 2021 Aug 16;76:e2981.Full text Abstract
84. Chou AJ, Bing RS, Ding DC. Endometrial atypical hyperplasia and risk of endometrial cancer. Diagnostics (Basel). 2024 Nov 5;14(22):2471.Full text Abstract
85. Emons G, Beckmann MW, Schmidt D, et al. New WHO classification of endometrial hyperplasias. Geburtshilfe Frauenheilkd. 2015 Feb;75(2):135-6.Full text Abstract
86. McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974;3(0):425-41. Abstract
87. Allaire C, Yong PJ, Bajzak K, et al. Guideline no. 445: management of chronic pelvic pain. J Obstet Gynaecol Can. 2024 Jan;46(1):102283.Full text Abstract
88. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013 Apr;121(4):891-6.Full text Abstract
89. Bofill Rodriguez M, Dias S, Jordan V, et al. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis. Cochrane Database Syst Rev. 2022 May 31;(5):CD013180.Full text Abstract
90. Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2020 Jun 12;(6):CD002126.Full text Abstract
91. Imai A, Matsunami K, Takagi H, et al. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clin Exp Obstet Gynecol. 2014;41(5):495-8. Abstract
92. Sheng J, Zhang WY, Zhang JP, et al. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009 Mar;79(3):189-93. Abstract
93. Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015 Aug;54(4):412-5.Full text Abstract
94. Bragheto AM, Caserta N, Bahamondes L, et al. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007 Sep;76(3):195-9. Abstract
95. Choi YS, Cho S, Lim KJ, et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis. Growth Factors. 2010 Dec;28(6):452-60. Abstract
96. Ozdegirmenci O, Kayikcioglu F, Akgul MA, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril. 2011 Feb;95(2):497-502.Full text Abstract
97. Shaaban OM, Ali MK, Sabra AM, et al. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial. Contraception. 2015 Oct;92(4):301-7. Abstract
98. Cope AG, Ainsworth AJ, Stewart EA. Current and future medical therapies for adenomyosis. Semin Reprod Med. 2020 May;38(2-03):151-6. Abstract
99. Sharafi K, Kunze K, Nosher JL, et al. Symptomatic fibroids: the need to include low dose OCPs as a treatment option. Prim Care Update OB GYNS. 2000 Jan;7(1):46-8.Full text
100. Yamanaka A, Kimura F, Kishi Y, et al. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells. Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:170-4.Full text Abstract
101. Vannuccini S, Luisi S, Tosti C, et al. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril. 2018 Mar;109(3):398-405.Full text Abstract
102. Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol. 2003 Apr;101(4):653-61. Abstract
103. Muneyyirci-Delale O, Chandrareddy A, Mankame S, et al. Norethindrone acetate in the medical management of adenomyosis. Pharmaceuticals (Basel). 2012 Oct 22;5(10):1120-7.Full text Abstract
104. Fawzy M, Mesbah Y. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial. Arch Gynecol Obstet. 2015 Dec;292(6):1267-71. Abstract
105. Hirata T, Izumi G, Takamura M, et al. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecol Endocrinol. 2014 Oct;30(10):726-9. Abstract
106. Osuga Y, Fujimoto-Okabe H, Hagino A. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril. 2017 Oct;108(4):673-8.Full text Abstract
107. Neriishi K, Hirata T, Fukuda S, et al. Long-term dienogest administration in patients with symptomatic adenomyosis. J Obstet Gynaecol Res. 2018 Aug;44(8):1439-44. Abstract
108. Marjoribanks J, Ayeleke RO, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul 30;(7):CD001751.Full text Abstract
109. Etrusco A, Barra F, Chiantera V, et al. Current medical therapy for adenomyosis: from bench to bedside. Drugs. 2023 Nov;83(17):1595-611.Full text Abstract
110. Bofill Rodriguez M, Lethaby A, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019 Sep 19;(9):CD000400.Full text Abstract
111. Gleeson NC, Buggy F, Sheppard BL, et al. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand. 1994 Mar;73(3):274-7. Abstract
112. Ishihara H, Kitawaki J, Kado N, et al. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril. 2003 Mar;79 Suppl 1:735-42.Full text Abstract
113. Khan KN, Kitajima M, Hiraki K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 2010 Mar;25(3):642-53. Abstract
114. Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand. 2012 Apr;91(4):489-95.Full text Abstract
115. Sauerbrun-Cutler MT, Alvero R. Short- and long-term impact of gonadotropin-releasing hormone analogue treatment on bone loss and fracture. Fertil Steril. 2019 Nov;112(5):799-803.Full text Abstract
116. Streuli I, Dubuisson J, Santulli P, et al. An update on the pharmacological management of adenomyosis. Expert Opin Pharmacother. 2014 Nov;15(16):2347-60. Abstract
117. Wang PH, Yang TS, Lee WL, et al. Treatment of infertile women with adenomyosis with a conservative microsurgical technique and a gonadotropin-releasing hormone agonist. Fertil Steril. 2000 May;73(5):1061-2.Full text Abstract
118. Huang BS, Seow KM, Tsui KH, et al. Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients. Taiwan J Obstet Gynecol. 2012 Jun;51(2):212-6.Full text Abstract
119. Ozaki T, Takahashi K, Okada M, et al. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int J Fertil Womens Med. 1999 Sep-Oct;44(5):260-4. Abstract
120. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017 Sep;108(3):483-90.e3.Full text Abstract
121. Cozzolino M, Tartaglia S, Pellegrini L, et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis. Reprod Sci. 2022 Nov;29(11):3177-93. Abstract
122. Stewart EA, Missmer SA, Rocca WA. Moving beyond reflexive and prophylactic gynecologic surgery. Mayo Clin Proc. 2021 Feb;96(2):291-4.Full text Abstract
123. American College of Obstetricians and Gynecologists. Committee opinion no 701: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017 Jun;129(6):e155-9.Full text Abstract
124. Taran FA, Weaver AL, Coddington CC, et al. Understanding adenomyosis: a case control study. Fertil Steril. 2010 Sep;94(4):1223-8.Full text Abstract
125. Baekelandt J. Total vaginal NOTES hysterectomy: a new approach to hysterectomy. J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1088-94. Abstract
126. Chen J, Porter AE, Kho KA. Current and future surgical and interventional management options for adenomyosis. Semin Reprod Med. 2020 May;38(2-03):157-67. Abstract
127. Knaepen S, van Calenbergh S. First-generation endometrial ablation revisited: retrospective outcome study - a series of 218 patients with premenopausal dysfunctional bleeding. Gynecol Surg. 2015 Jul 9;12(4):291-7.Full text
128. Liu L, Wang T, Lei B. Image-guided thermal ablation in the management of symptomatic adenomyosis: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):948-62.Full text Abstract
129. Scarperi S, Pontrelli G, Campana C, et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis. JSLS. 2015 Sep-Dec;19(4):e2015.00071.Full text Abstract
130. Hai N, Hou Q, Ding X, et al. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis. Br J Radiol. 2017 Jan;90(1069):20160119.Full text Abstract
131. Hai N, Zhang J, Xu R, et al. Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience. Int J Hyperthermia. 2017 Sep;33(6):646-52.Full text Abstract
132. Li S, Li Z, Lin M, et al. Efficacy of transabdominal ultrasound-guided percutaneous microwave ablation in the treatment of symptomatic adenomyosis: a retrospective cohort study. J Minim Invasive Gynecol. 2023 Feb;30(2):137-46. Abstract
133. Liu JX, Li JY, Zhao XY, et al. Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation for adenomyosis: preliminary results. Int J Hyperthermia. 2019;36(1):1232-7.Full text Abstract
134. National Institute for Health and Care Excellence. Uterine artery embolisation for treating adenomyosis. Dec 2013 [internet publication].Full text
135. Rabinovici J, Stewart EA. New interventional techniques for adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):617-36. Abstract
136. Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007 Jan;188(1):176-81.Full text Abstract
137. de Bruijn AM, Smink M, Hehenkamp WJK, et al. Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire. Cardiovasc Intervent Radiol. 2017 Sep;40(9):1344-50.Full text Abstract
138. Liang E, Brown B, Rachinsky M. A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: results in 117 women. Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):454-9. Abstract
139. Zhou J, He L, Liu P, et al. Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases. PLoS One. 2016 Nov 2;11(11):e0165610.Full text Abstract
140. Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012 Aug;35(4):815-9. Abstract
141. Hlinecka K, Mara M, Boudova B, et al. Comparison of clinical and reproductive outcomes between adenomyomectomy and myomectomy. J Minim Invasive Gynecol. 2022 Mar;29(3):392-400. Abstract
142. Hyams LL. Adenomyosis; its conservative surgical treatment (hysteroplasty) in young women. N Y State J Med. 1952 Nov 15;52(22):2778-84. Abstract
143. Osada H, Silber S, Kakinuma T, et al. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online. 2011 Jan;22(1):94-9.Full text Abstract
144. Fujishita A, Masuzaki H, Khan KN, et al. Modified reduction surgery for adenomyosis. A preliminary report of the transverse H incision technique. Gynecol Obstet Invest. 2004;57(3):132-8. Abstract
145. Kwack JY, Im KS, Kwon YS. Conservative surgery of uterine adenomyosis via laparoscopic versus laparotomic approach in a single institution. J Obstet Gynaecol Res. 2018 Jul;44(7):1268-73. [Erratum in: J Obstet Gynaecol Res. 2018 Sep;44(9):1866.] Abstract
146. Shim JI, Jo EH, Kim M, et al. A comparison of surgical outcomes between robot and laparoscopy-assisted adenomyomectomy. Medicine (Baltimore). 2019 May;98(18):e15466.Full text Abstract
147. Kang L, Gong J, Cheng Z, et al. Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion. J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):169-73. Abstract
148. Kwon YS, Roh HJ, Ahn JW, et al. Conservative adenomyomectomy with transient occlusion of uterine arteries for diffuse uterine adenomyosis. J Obstet Gynaecol Res. 2015 Jun;41(6):938-45. Abstract
149. Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018 Mar;109(3):406-17.Full text Abstract
150. Al Jama FE. Management of adenomyosis in subfertile women and pregnancy outcome. Oman Med J. 2011 May;26(3):178-81.Full text Abstract
151. Wang PH, Liu WM, Fuh JL, et al. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril. 2009 Sep;92(3):876-85.Full text Abstract
152. Kwack JY, Lee SJ, Kwon YS. Pregnancy and delivery outcomes in the women who have received adenomyomectomy: performed by a single surgeon by a uniform surgical technique. Taiwan J Obstet Gynecol. 2021 Jan;60(1):99-102.Full text Abstract
153. Mikos T, Lioupis M, Anthoulakis C, et al. The outcome of fertility-sparing and nonfertility-sparing surgery for the treatment of adenomyosis. A systematic review and meta-analysis. J Minim Invasive Gynecol. 2020 Feb;27(2):309-31.e3. Abstract
154. Becker CM, Bokor A, Heikinheimo O, et al; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022 Feb 26;2022(2):hoac009.Full text Abstract
155. Yamamoto T, Noguchi T, Tamura T, et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol. 1993 Sep;169(3):734-8. Abstract
156. Stratopoulou CA, Donnez J, Dolmans MM. Conservative management of uterine adenomyosis: medical vs. surgical approach. J Clin Med. 2021 Oct 22;10(21):4878.Full text Abstract
157. Donnez O, Donnez J. Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis. Fertil Steril. 2020 Sep;114(3):640-5.Full text Abstract
158. Donnez J, Donnez O, Dolmans MM. Evolution of uterine adenomyosis volume during and after GnRH antagonist (linzagolix) treatment: lessons for further clinical trials. Fertil Steril. 2023 Nov;120(5):1071-3.Full text Abstract
159. Donnez J, Donnez O, Brethous M, et al. Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study. Reprod Biomed Online. 2022 Jan;44(1):200-3. Abstract
160. Murji A, Whitaker L, Chow TL, et al. Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database Syst Rev. 2017 Apr 26;(4):CD010770.Full text Abstract
161. Gonçalves-Henriques M, de Pinho A, Freixo M, et al. Ulipristal acetate in adenomyosis. Gynecol Minim Invasive Ther. 2022 Oct-Dec;11(4):198-202.Full text Abstract
162. Gracia M, Alcalà M, Ferreri J, et al. Ulipristal acetate improves clinical symptoms in women with adenomyosis and uterine myomas. J Minim Invasive Gynecol. 2018 Nov-Dec;25(7):1274-80. Abstract
163. Che X, Wang J, He J, et al. The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea. Int J Med Sci. 2020 Jan 14;17(2):224-33.Full text Abstract
164. Capmas P, Brun JL, Legendre G, et al. Ulipristal acetate use in adenomyosis: a randomized controlled trial. J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101978. Abstract
165. Conway F, Morosetti G, Camilli S, et al. Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids. Gynecol Endocrinol. 2019 Mar;35(3):207-10. Abstract
166. Hong YH, Han SJ, Lee D, et al. Adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas and/or adenomyosis. J Obstet Gynaecol Res. 2019 Apr;45(4):865-70. Abstract
167. Middelkoop MA, Bet PM, Drenth JPH, et al. Risk-efficacy balance of ulipristal acetate compared to surgical alternatives. Br J Clin Pharmacol. 2021 Jul;87(7):2685-97.Full text Abstract
168. Cheung VYT. High-intensity focused ultrasound therapy. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:74-83. Abstract
169. Fukunishi H, Funaki K, Sawada K, et al. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):571-9. Abstract
170. Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011 Mar 1;95(3):900-5.Full text Abstract
171. Ferrari F, Arrigoni F, Miccoli A, et al. Effectiveness of magnetic resonance-guided focused ultrasound surgery (MRgFUS) in the uterine adenomyosis treatment: technical approach and MRI evaluation. Radiol Med. 2016 Feb;121(2):153-61. Abstract
172. Fan TY, Zhang L, Chen W, et al. Feasibility of MRI-guided high intensity focused ultrasound treatment for adenomyosis. Eur J Radiol. 2012 Nov;81(11):3624-30. Abstract
173. Polina L, Nyapathy V, Mishra A, et al. Noninvasive treatment of focal adenomyosis with MR-guided focused ultrasound in two patients. Indian J Radiol Imaging. 2012 Apr;22(2):93-7.Full text Abstract
174. Pang LL, Mei J, Fan LX, et al. Efficacy of high-intensity focused ultrasound combined with GnRH-a for adenomyosis: a systematic review and meta-analysis. Front Public Health. 2021 Aug 16;9:688264.Full text Abstract
175. Zhao TT, Pang LL, Yang LL, et al. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023 Aug;308(2):351-62. Abstract
176. Moawad G, Feki A, Ayoubi JM, et al. Tips and tricks for robotic management of diffuse adenomyosis. Fertil Steril. 2024 Nov 29 [Epub ahead of print]. Abstract
177. Tan J, Moriarty S, Taskin O, et al. Reproductive outcomes after fertility-sparing surgery for focal and diffuse adenomyosis: a systematic review. J Minim Invasive Gynecol. 2018 May-Jun;25(4):608-21. Abstract
178. Zhou Y, Shen L, Wang Y, et al. Long-term pregnancy outcomes of patients with diffuse adenomyosis after double-flap adenomyomectomy. J Clin Med. 2022 Jun 17;11(12):3489.Full text Abstract
179. Wu R, Zeng L, Hu Q, et al. Outcome of uterine functional structures protection by fertility preservative PUSH surgery in diffuse adenomyosis. Hum Fertil (Camb). 2023 Oct;26(4):720-32.Full text Abstract
180. Xia W, Zhang D, Zhu Q, et al. Hysteroscopic excision of symptomatic myometrial adenomyosis: feasibility and effectiveness. BJOG. 2017 Sep;124(10):1615-20. Abstract
181. Wheeler TL 2nd, Murphy M, Rogers RG, et al. Clinical practice guideline for abnormal uterine bleeding: hysterectomy versus alternative therapy. J Minim Invasive Gynecol. 2012 Jan-Feb;19(1):81-8. Abstract
182. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000 May;95(5):688-91. Abstract
183. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998 Jul-Aug;4(4):323-36. Abstract
184. Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014 May;10(5):261-75. Abstract
Use of this content is subject to our disclaimer